| Janssen-Cilag AG - Rybrevant SC 2240 mg/14 ml, Injektionslösung | | 69839 | | 02 | | Rybrevant SC 2240 mg/14 ml | | Injektionslösung | | L01FX18 | | Amivantamab | | 28.01.2026 | | |
| | Composition | | amivantamabum 2240 mg, hyaluronidasum humanum ADNr, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 80 8.4 mg, methioninum, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 14 ml corresp. natrium 8.66 mg. | | Packungsbestandteile | | Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Amivantamabum | 2240mg / 14ml |
| | BAG: Active Agent | Dose |
|---|
| Amivantamabum | 2240 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Aceticum Glaciale | | | Dinatrii Edetas | | | Hyaluronidasum Humanum Adnr | | | Methionine | | | Natrii Acetas Trihydricus | | | Polysorbatum 80 | 8.4mg / 14ml | | Saccharum | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 4717.36 | 5146.85 | A | SL | No |
|
|
